Literature DB >> 11682498

Correlation between mutations in the interferon sensitivity-determining region of NS5A protein and viral load of hepatitis C virus subtypes 1b, 1c, and 2a.

M I Lusida1, M Nagano-Fujii, C A Nidom, R Handajani, T Fujita, K Oka, H Hotta.   

Abstract

In the present study, we analyzed the possible relationship between interferon (IFN) sensitivity-determining region (ISDR) sequence variation of various hepatitis C virus (HCV) subtypes and serum HCV titers in Indonesian patients without IFN treatment. The viremia titers (mean +/- standard deviation) of HCV subtype 1b (HCV-1b) isolates with low (three or fewer) and high (four or more) numbers of ISDR mutations were 5.4 +/- 0.6 and 4.2 +/- 0.9 log(10) RNA copies/ml, respectively, with the difference between the two groups being statistically significant (P < 0.01). Similarly, the viremia titers of HCV-1c isolates with low and high numbers of ISDR mutations were 5.3 +/- 0.6 and <3.0 +/- 0.0 log(10) RNA copies/ml, respectively, with the difference between the two groups being statistically significant (P < 0.01). Also, the virus titers of HCV-2a isolates with low and high numbers of ISDR mutations were 4.3 +/- 0.7 and 3.5 +/- 0.4 log(10) RNA copies/ml, respectively, with the difference between the two groups being statistically significant (P < 0.01). Thus, our results demonstrated that virus load in Indonesian patients infected with HCV-1b, HCV-1c, or HCV-2a correlated inversely with the number of mutations in the ISDR sequence, implying the possibility that the ISDR sequence plays an important role in determining the levels of HCV viremia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11682498      PMCID: PMC88455          DOI: 10.1128/JCM.39.11.3858-3864.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions.

Authors:  H Okamoto; S Okada; Y Sugiyama; K Kurai; H Iizuka; A Machida; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1991-11       Impact factor: 3.891

2.  Subtype analysis of hepatitis C virus in Indonesia on the basis of NS5b region sequences.

Authors:  H Hotta; R Handajani; M I Lusida; W Soemarto; H Doi; H Miyajima; M Homma
Journal:  J Clin Microbiol       Date:  1994-12       Impact factor: 5.948

3.  Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy.

Authors:  J Nousbaum; S J Polyak; S C Ray; D G Sullivan; A M Larson; R L Carithers; D R Gretch
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis.

Authors:  N Kato; M Hijikata; Y Ootsuyama; M Nakagawa; S Ohkoshi; T Sugimura; K Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

5.  Analysis of the core and E1 envelope region sequences of a novel variant of hepatitis C virus obtained in Indonesia.

Authors:  H Hotta; H Doi; T Hayashi; M Purwanta; W Soemarto; M Mizokami; K Ohba; M Homma
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  The entire nucleotide sequence and classification of a hepatitis C virus isolate of a novel genotype from an Indonesian patient with chronic liver disease.

Authors:  H Okamoto; M Kojima; M Sakamoto; H Iizuka; S Hadiwandowo; S Suwignyo; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1994-03       Impact factor: 3.891

7.  Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region.

Authors:  P Simmonds; E C Holmes; T A Cha; S W Chan; F McOmish; B Irvine; E Beall; P L Yap; J Kolberg; M S Urdea
Journal:  J Gen Virol       Date:  1993-11       Impact factor: 3.891

8.  Mutations in hepatitis C virus RNAs conferring cell culture adaptation.

Authors:  V Lohmann; F Körner; A Dobierzewska; R Bartenschlager
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

9.  Efficient initiation of HCV RNA replication in cell culture.

Authors:  K J Blight; A A Kolykhalov; C M Rice
Journal:  Science       Date:  2000-12-08       Impact factor: 47.728

10.  Mutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infection.

Authors:  T Murakami; N Enomoto; M Kurosaki; N Izumi; F Marumo; C Sato
Journal:  Hepatology       Date:  1999-10       Impact factor: 17.425

View more
  9 in total

1.  Identification of hepatitis C virus (HCV) subtype 1b strains that are highly, or only weakly, associated with hepatocellular carcinoma on the basis of the secondary structure of an amino-terminal portion of the HCV NS3 protein.

Authors:  Satoshi Ogata; Ruth Huab Florese; Motoko Nagano-Fujii; Rachmat Hidajat; Lin Deng; Yonson Ku; Seitetsu Yoon; Takafumi Saito; Sumio Kawata; Hak Hotta
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

2.  Comparative sequence analysis of the core protein and its frameshift product, the F protein, of hepatitis C virus subtype 1b strains obtained from patients with and without hepatocellular carcinoma.

Authors:  Satoshi Ogata; Motoko Nagano-Fujii; Yonson Ku; Seitetsu Yoon; Hak Hotta
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

3.  Novel subgenotypes of hepatitis B virus genotypes C and D in Papua, Indonesia.

Authors:  Maria Inge Lusida; Victor Eka Nugrahaputra; Retno Handajani; Motoko Nagano-Fujii; Mikiko Sasayama; Takako Utsumi; Hak Hotta
Journal:  J Clin Microbiol       Date:  2008-05-07       Impact factor: 5.948

4.  New resistance-associated substitutions and failure of dual oral therapy with daclatasvir and asunaprevir.

Authors:  Seiichi Mawatari; Kohei Oda; Kazuaki Tabu; Sho Ijuin; Kotaro Kumagai; Yukiko Inada; Hirofumi Uto; Yasunari Hiramine; Takeshi Kure; Kunio Fujisaki; Masafumi Hashiguchi; Takeshi Hori; Akihiko Oshige; Dai Imanaka; Akiko Saishoji; Oki Taniyama; Haruka Sakae; Tsutomu Tamai; Akihiro Moriuchi; Akio Ido
Journal:  J Gastroenterol       Date:  2017-01-11       Impact factor: 6.772

5.  Sequence heterogeneity in NS5A of hepatitis C virus genotypes 2a and 2b and clinical outcome of pegylated-interferon/ribavirin therapy.

Authors:  Ahmed El-Shamy; Ikuo Shoji; Soo-Ryang Kim; Yoshihiro Ide; Susumu Imoto; Lin Deng; Seitetsu Yoon; Takashi Fujisawa; Satoshi Tani; Yoshihiko Yano; Yasushi Seo; Takeshi Azuma; Hak Hotta
Journal:  PLoS One       Date:  2012-02-02       Impact factor: 3.240

6.  The co-existence of NS5A and NS5B resistance-associated substitutions is associated with virologic failure in Hepatitis C Virus genotype 1 patients treated with sofosbuvir and ledipasvir.

Authors:  Seiichi Mawatari; Kohei Oda; Kazuaki Tabu; Sho Ijuin; Kotaro Kumagai; Kunio Fujisaki; Masafumi Hashiguchi; Yukiko Inada; Hirofumi Uto; Yasunari Hiramine; Takeshi Kure; Takeshi Hori; Oki Taniyama; Ai Kasai; Tsutomu Tamai; Akihiro Moriuchi; Akio Ido
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

7.  In-Vitro Transcription analysis of NS5A from HCV-3a circulating in Pakistani patients with chronic hepatitis C and their differential response to antiviral therapy.

Authors:  Shameem Bhatti; Sobia Manzoor; Fahed Parvaiz; Javed Ashraf; Farakh Javed
Journal:  Pak J Med Sci       Date:  2017 Sep-Oct       Impact factor: 1.088

8.  Genetic variability of hepatitis C virus before and after combined therapy of interferon plus ribavirin.

Authors:  José Manuel Cuevas; Manuela Torres-Puente; Nuria Jiménez-Hernández; María Alma Bracho; Inmaculada García-Robles; Boris Wrobel; Fernando Carnicer; Juan del Olmo; Enrique Ortega; Andrés Moya; Fernando González-Candelas
Journal:  PLoS One       Date:  2008-08-26       Impact factor: 3.240

9.  An increased diversity of HCV isolates were characterized among 393 patients with liver disease in China representing six genotypes, 12 subtypes, and two novel genotype 6 variants.

Authors:  Lin Gu; Wangxia Tong; Manqiong Yuan; Teng Lu; Chunhua Li; Ling Lu
Journal:  J Clin Virol       Date:  2013-05-21       Impact factor: 3.168

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.